| 000 | 01566 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513063018.0 | ||
| 264 | 0 | _c19940512 | |
| 008 | 199405s 0 0 eng d | ||
| 022 | _a0090-4295 | ||
| 024 | 7 |
_a10.1016/0090-4295(94)90242-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDinney, C P | |
| 245 | 0 | 0 |
_aTherapy and prognosis for male anterior urethral carcinoma: an update. _h[electronic resource] |
| 260 |
_bUrology _cApr 1994 |
||
| 300 |
_a506-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmortality |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xmortality |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymph Node Excision |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUrethral Neoplasms _xmortality |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aJohnson, D E | |
| 700 | 1 | _aSwanson, D A | |
| 700 | 1 | _aBabaian, R J | |
| 700 | 1 | _avon Eschenbach, A C | |
| 773 | 0 |
_tUrology _gvol. 43 _gno. 4 _gp. 506-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-4295(94)90242-9 _zAvailable from publisher's website |
| 999 |
_c8153397 _d8153397 |
||